The efficacy and feasibility of weekly 5-FU and cisplatin based radical concurrent chemoradiation therapy(CRT) in patients with esophageal cancer.

被引：0
|
作者：
Jeong, Joon Won
Yang, Ji Hyun
Ro, Sang Mi
Kim, In-Ho
Roh, Sang Young
机构：
[1] Catholic Univ Korea, Seoul St Marys Hosp, Div Med Oncol, Dept Internal Med, Seoul, South Korea
[2] Seoul St Marys Hosp, Div Oncol, Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.169
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
169
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer
    Roof, Kevin S.
    Coen, John
    Lynch, Thomas J.
    Wright, Cameron
    Fidias, Panos
    Willett, Christopher G.
    Choi, Noah C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (04): : 1120 - 1128
  • [2] SAFETY AND EFFICACY OF CONCURRENT WEEKLY CISPLATIN AND 5-FU ALONG WITH RADIOTHERAPY IN INOPERABLE SQUAMOUS CELL CANCER OF ESOPHAGUS
    Kumar, S.
    Khurana, R.
    Sapru, S.
    Datta, N.
    Das, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 83 - 83
  • [3] Chemoradiation therapy for cervical cancer: Toxicity of concurrent weekly cisplatin
    Ikushima H.
    Osaki K.
    Furutani S.
    Yamashita K.
    Kawanaka T.
    Kishida Y.
    Iwamoto S.
    Takegawa Y.
    Kudoh T.
    Nishitani H.
    Radiation Medicine, 2006, 24 (2): : 115 - 121
  • [4] Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine after radical gastrectomy for advanced gastric cancer
    Lee, H.
    Choi, Y.
    Hur, W.
    Kwon, H.
    Kim, M.
    Jung, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S303 - S304
  • [5] Paclitaxel-based therapy no better than cisplatin and 5-FU for operable esophageal cancer
    Nature Clinical Practice Oncology, 2008, 5 (1): : 7 - 8
  • [6] Concurrent chemoradiotherapy with protracted infusion of 5-FU and cisplatin for postoperative recurrent or residual esophageal cancer
    Nishimura, Y
    Koike, R
    Nakamatsu, K
    Kanamori, S
    Suzuki, M
    Shigeoka, H
    Shiozaki, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (07) : 341 - 345
  • [7] Comparison of chemoradiotherapy (CRT) using carboplatin/paclitaxel (CP) versus cisplatin/5-FU (CF) for esophageal or gastroesophageal junctional (GEJ) cancer.
    Sim, Hao-Wen
    Chan, Bryan Anthony
    Natori, Akina
    Lim, Charles Henry
    Jiang, Di Maria
    Moignard, Stephanie
    Chen, Eric Xueyu
    Liu, Geoffrey
    Darling, Gail Elizabeth
    Swallow, Carol Jane
    Brar, Savtaj Singh
    Brierley, James D.
    Ringash, Jolie
    Wong, Rebecca
    Kim, John
    Rogalla, Patrik
    Hafezi-Bakhtiari, Sara
    Knox, Jennifer J.
    Jang, Raymond Woo -Jun
    Elimova, Elena
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Phase I Study of Definitive Chemoradiation With Cisplatin/5-FU Plus Cetuximab in Unresectable Esophageal Cancer
    Rades, D.
    Moehler, M. H.
    Schmidberger, H.
    Fellermann, K.
    Buerk, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S450 - S450
  • [9] Neo-adjuvant radiation, cisplatin, 5-FU +/- paclitaxel in locally advanced esophageal cancer.
    Roof, KS
    Coen, J
    Lynch, TJ
    Wright, CD
    Fidias, P
    Willett, CG
    Choi, NC
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 324S - 324S
  • [10] Concurrent hypofractionated chemoradiation (CRT) for head and neck squamous cancer with weekly cisplatin: A Lancashire experience
    Sivaramalingam, M.
    Mehta, A.
    Wong, H.
    Sidek, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345